Cold, Flu & COVID-19
Rebound COVID Treatment
We are now enrolling for a clinical trial evaluating the effectiveness of an investigational medication on rebound COVID-19 outcomes.
We have partnered with sponsors who are researching the effectiveness of an investigational oral treatment on the outcomes of high risk individuals who are experiencing rebound COVID-19 symptoms.
High risk adults and children who have a current diagnosis of COVID-19 may qualify.
Type 2 Diabetes Medication Study
We are currently looking for interested participants for an upcoming study evaluating an investigational oral medication vs. insulin in the management of type two diabetes.
Adults with Type 2 Diabetes who are overweight and have a diagnosis kidney disease or cardiovascular disease may qualify.
Cancer Detection Study
We are now enrolling for a clinical trial which is working to improve existing cancer detection lab diagnostic technology.
This is a study collecting a single blood sample from individuals with and without cancer to evaluate current diagnostic technology for cancer. These samples may also be used in the development of future tests.
Adults with benign conditions and/or cancer may qualify.
Cardiovascular Risk Outcomes in Overweight Adults
We are now enrolling for a clinical trial evaluating the effectiveness of an investigational medication on cardiovascular outcomes in high risk overweight adults.
This study is evaluating an investigational medication vs placebo on the long term morbidity and mortality of adults who are overweight and have other cardiovascular risk factors.
High risk adults over 40 years of age with a BMI of 27 or more may qualify.
We are currently enrolling for studies in a number of areas, even if the studies are not published publicly below. If you cannot find what you are looking for today, you may contact email@example.com or call (425) 869-6828 to speak with a member of our research team.